Glimpse Group, Inc. 8-K

What Happened
Glimpse Group, Inc. (GGRP) announced on May 14, 2026 that it entered into a Securities Purchase Agreement for a registered direct offering expected to close on or about May 18, 2026. The Company agreed to sell 622,306 shares of common stock with accompanying warrants, warrants to purchase up to 4,193,182 additional shares (each warrant exercisable for 1.25 shares), and, for certain investors, pre‑funded warrants to purchase up to 2,732,240 shares. The combined purchase price was $0.55 per share-plus-warrant and $0.549 for each pre‑funded warrant-plus-warrant, with net proceeds to the Company expected to be approximately $1.79 million after estimated offering expenses. The Company sold the securities directly to investors and did not retain a placement agent or underwriter.

Key Details

• Securities and pricing: 622,306 common shares sold; warrants to buy up to 4,193,182 shares (1.25 shares per warrant); pre‑funded warrants covering 2,732,240 shares. Unit pricing: $0.55 (share + warrant) and $0.549 (pre‑funded warrant + warrant). Net proceeds ≈ $1.79M.
• Exercise terms: Pre‑funded warrants are immediately exercisable at $0.001 per share. Common Stock Warrants are exercisable six months after issuance, expire 7.5 years from issuance, and have an exercise price of $0.55 per share (each warrant converts into 1.25 shares).
• Ownership limits & rights: Exercise is subject to a beneficial ownership cap of 9.99% of outstanding common stock (adjustable with 61 days’ notice up to a 19.99% maximum). Investors also received participation rights to buy up to 33.33% of securities in future equity or equity‑linked financings for 12 months after closing (subject to customary exceptions).
• Process and filings: Offering made under the company’s effective Form S‑3 shelf; closing is subject to customary conditions. Legal opinion and press release were filed as exhibits to the 8‑K.

Why It Matters
This offering provides Glimpse with immediate capital (about $1.79M) to support operations or other corporate needs, but the attached warrants and pre‑funded warrants represent potential future dilution if exercised. Key investor protections—such as the 9.99% ownership cap and the six‑month delay before warrant exercise—affect how and when dilution could occur. The participation rights granted to these investors could influence the structure and size of future financings over the next year. Investors should watch for the closing (expected May 18, 2026), any use‑of‑proceeds disclosures, and future filings that report cash impact and dilution if warrants are exercised.